Nominated companies

The six nominated companies for the Strictly Financing Award 2007 are:

Astion Pharma

Astion Pharma focuses on research and development of products for the treatment of inflammatory dermatological and immunological diseases.
6 products in clinical development.
30 employees.

Camurus specialises in the development of pharmaceuticals based on advanced and effective drug delivery solutions that optimize the bioavailability and therapeutic performance of a wide range of difficult substances, including: peptides, proteins, and insoluble small molecules.
3 products in clinical development.
20 employees.

Egalet

Egalet is focused on erosion-based drug delivery with a pipeline of compounds in advanced clinical trials for the cardiovascular and pain management markets.
4 products in clinical development.
55 employees.

NatImmune

NatImmune is focusing on the development of protein-based therapeutics for the prevention and treatment of cancer and infectious diseases.
1 product in clinical development.
30 employees.

Santaris Pharma

Santaris Pharma is a science-based, product-driven, biopharmaceutical company focused on oncology.
3 products in clinical development.
60 employees.

Symphogen

Symphogen is developing a product pipeline that targets diseases caused by complex antigens. These diseases include infectious diseases, cancer, transplant rejection and allergy.
2 products in clinical development.
80 employees

Nomination criteria

The nominated companies are drug delivery and/or development companies and members of Medicon Valley Academy. The following criteria have been decisive for the nomination:

- Initiation of clinical programme
- Strong pipeline
- Strong investor base
- Strong financial development
- Important agreements (i.e. license agreements)
- Strong management
- Other strategically important activities
- Unique business case
- High growth potential